A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection

NCT03024177 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study is withdrawn due to company decision

Conditions

Rhinovirus
Upper Respiratory Tract Infection

Interventions

DRUG: Vapendavir
DRUG: Placebo Oral Tablet

Sponsor

Vaxart